<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Normotensive and hypertensive male Wistar rats were subjected to the 3 h bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 72 h of reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>The selective cycloxygenase-2 inhibitor meloxicam was administered intramuscularly after the cerebral reperfusion at a daily dose of 15 mg/kg </plain></SENT>
<SENT sid="2" pm="."><plain>Doppler ultrasound was used to evaluate the cerebral blood flow during the reperfusion phase </plain></SENT>
<SENT sid="3" pm="."><plain>The level of malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) within the brain tissue homogenate was determined using spectrophotometry </plain></SENT>
<SENT sid="4" pm="."><plain>The presence of arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> caused the altered response of brain tissue to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>The meloxicam treatment significantly decreased the <z:chebi fb="14" ids="32506">MDA</z:chebi> level in normotensive rats subjected to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>The protective effect of meloxicam against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion injury was more pronounced in hypertensive rats as compared to normotensive animals </plain></SENT>
</text></document>